Living

beauty.

Living

beauty.

We are Etienna Bio

Our Mission is to transform aesthetic medicine by offering a new standard: living, autologous tissue instead of temporary synthetics.

Through proprietary cell expansion and differentiation technology, we enable patients to achieve natural, permanent results in breast augmentation, reconstruction, fat transfer, and facial rejuvenation using their own biology – not foreign materials.

Our Story

Etienna Bio was founded on a simple question:

Why can’t aesthetic medicine use a patient’s own cells to create long-lasting, natural results?

The answer came from groundbreaking research at the University of Massachusetts, where scientists developed a proprietary method to expand stem cells from a small fat sample by more than 1,000-fold—and then differentiate them into adipocytes or collagen-producing fibroblasts.

We recognized the potential immediately. That’s when Etienna Bio was born: to bring this science out of the lab and into the lives of patients who deserve better.

Discover The Platform

Our Leadership

team.

Etienna’s leadership team brings deep expertise in cell therapy, regenerative medicine, and aesthetic surgery, with a combined track record of 100+ FDA approvals.

Our scientific founders partner with University of Massachusetts researchers and are supported by an 11-member Technical Scientific Oversight board.

Janet DeLeon

Co-Founder, President & CEO

Missy Clifton, MD

Co-Founder, Chief Medical Officer

Rob Lewis

Co-Founder, Chairman of the Board

Tim Dugan

Co-Founder, Chief Clinical Officer

Scientific Advisory

board.

Michael P. Czech, PhD

Chair of Medical Research | Molecular Medicine

Silvia Corvera, MD

Professor of Molecular Medicine

home
about us
our science
news & media
contact
invest

Janet DeLeon

Co-Founder, President & CEO

Janet DeLeon serves as President and CEO of Etienna Bio, Inc. Mrs. DeLeon has spent over 35 years working in the pharmaceutical industry. She progressed her career by assuming lead positions in Regulatory Affairs and Product Development in large and small pharmaceutical companies and consulting firms while gaining product approvals from the US FDA. For 12 years, she has been the owner and principal consultant of a regulatory and product development consulting firm developing new products from scratch. Janet has interacted with the US FDA for over 30 years by submitting, defending and gaining approval for hundreds of applications to the FDA. She was also president of PTEA, an FDA and Industry discussion group, for 12 years. Janet earned her B.S. in Chemistry from Quincy University and is certified in pharmaceutical Regulatory Affairs (RAC) by the Regulatory Affairs Professional Society.

Dr. Missy Clifton

Co-Founder, Chief Medical Officer

Dr. Missy Clifton serves as Co-Founder and Chief Medical Officer of Etienna Bio, Inc. Dr Clifton is a triple board-certified dermatologist, laser surgeon and integrative health physician. She holds board certifications from the American Board of Dermatology, the American Board of Laser Surgery, and the American Academy of Anti-Aging Medicine. She founded Premier Dermatology, Aesthetics and Wellness in Bentonville, Arkansas, in 2004 with the goal of creating a state-of-the-art practice with “All Things Skin Under One Roof.” Missy is also the founder of Clinical Trials Institute of Northwest Arkansas, where she participates in medical and cosmetic trials for new skin therapies and treatments. She is a coveted national trainer and speaker for many aesthetic and laser companies. She is also a specialty advisor to the Alice Walton school of medicine and mentors the medical students in the Dermatology interest club.

Robert Lewis

Co-Founder, Chairman of the Board

Rob Lewis serves as Co-Founder, Chairman and Director of Etienna Bio, Inc. Mr. Lewis spent the last 30 years working in the biotech and pharmaceutical industry, beginning at TEVA Pharmaceuticals and continuing with other multiple global and mid-tier pharmaceutical corporations such as Sigma and Cypress Pharmaceuticals. He has held leadership positions overseeing the departments of Scientific Affairs, Medical Affairs, Regulatory Affairs, Clinical Affairs, and International and Domestic Business Development. Additionally, Rob has 30 NDA and ANDA FDA drug approvals and multiple launches under his supervision. Since 2012, he has founded and taken multiple ownership stakes in other biotech, pharmaceutical, and medical device companies and serves on the board of directors for each company. Rob earned his B.S. in Chemistry and Biology from Columbia College.

Tim Dugan

Co-Founder, Chief Clinical Officer

Tim Dugan serves as the Co-Founder and Chief Clinical Officer of Etienna Bio, Inc. Mr. Dugan received a B.S. in Biology from the University of Arkansas at Little Rock. He began his career in clinical trial research at Physicians Group Research Clinic. While there, he successfully became the regional director of Clinical Operations for Research Solutions, a national site management organization based in Little Rock, Arkansas. He served as the director overseeing 10 clinical research sites and managed a dozen research coordinators. Tim has over 25 years of experience in clinical research. For twenty years, he has been the director of clinical operations for Burke Pharmaceutical Research. He also holds certifications from the Association of Clinical Research Professionals, Certified Clinical Research Coordinator (CCRC), Model Agreement Group Initiative, and Clinical Research Contract Professional (CRCP).

Send us a message and we will get back to you shortly!

Name